End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.28 CNY | -0.46% | -2.13% | -16.43% |
2023 | Yiling Pharmaceutical Gets Nod for China Clinical Trial of Tracheobronchitis Drug | MT |
2023 | Yiling Pharmaceutical's Lianhua Qingke Tablets Gets Nod to Become Over-the-Counter Drug; Shares Up 4% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.43% | 4.45B | |
+38.08% | 6.05B | |
-12.46% | 3.06B | |
-0.21% | 3.04B | |
-0.59% | 2.58B | |
+34.54% | 1.79B | |
+0.93% | 1.66B | |
-10.63% | 1.63B | |
-12.50% | 1.54B | |
+37.15% | 1.42B |
- Stock Market
- Equities
- 002603 Stock
- News Shijiazhuang Yiling Pharmaceutical Co., Ltd.
- Shijiazhuang Yiling’s Depression Drug Included in China’s Medical Insurance Catalog